| Target Price | $328.95 |
| Price | $262.23 |
| Potential | 25.44% |
| Number of Estimates | 50 |
| 50 Analysts have issued a price target Salesforce 2026 . The average Salesforce target price is $328.95. This is 25.44% higher than the current stock price. The highest price target is $464.10 76.98% , the lowest is $225.23 14.11% . | |
| A rating was issued by 58 analysts: 44 Analysts recommend Salesforce to buy, 13 to hold and 1 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
| Analyst Estimates: Analysts believe that the Salesforce stock has an average upside potential 2026 of 25.44% . Most analysts recommend the Salesforce stock at Purchase. |
55 Analysts have issued a sales forecast Salesforce 2026 . The average Salesforce sales estimate is $41.7b . This is 3.33% higher than the revenue of the last 12 months(TTM). The highest sales forecast is $43.6b 8.20% , the lowest is $40.3b 0.01% .
This results in the following potential growth metrics:
| 2025 | $37.9b | 8.72% |
|---|---|---|
| 2026 | $41.7b | 9.94% |
| 2027 | $45.4b | 9.01% |
| 2028 | $49.6b | 9.18% |
| 2029 | $54.8b | 10.59% |
| 2030 | $60.0b | 9.39% |
| 2031 | $65.6b | 9.42% |
| 2032 | $72.2b | 10.01% |
| 2033 | $79.6b | 10.18% |
26 Analysts have issued an Salesforce EBITDA forecast 2026. The average Salesforce EBITDA estimate is $17.4b . This is 77.79% higher than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is $18.6b 89.26% , the lowest is $15.7b 60.03% .
This results in the following potential growth metrics and future EBITDA Margins:
| 2025 | $8.6b | 24.34% |
|---|---|---|
| 2026 | $17.4b | 103.48% |
| 2027 | $18.7b | 7.42% |
| 2028 | $19.8b | 5.87% |
| 2029 | $23.0b | 15.98% |
| 2030 | $26.0b | 12.96% |
| 2031 | $17.8b | 31.39% |
| 2032 | $19.7b | 10.49% |
| 2033 | $21.7b | 10.29% |
| 2025 | 22.61% | 14.37% |
|---|---|---|
| 2026 | 41.84% | 85.07% |
| 2027 | 41.23% | 1.46% |
| 2028 | 39.98% | 3.03% |
| 2029 | 41.93% | 4.88% |
| 2030 | 43.30% | 3.27% |
56 Salesforce Analysts have issued a net profit forecast 2026. The average Salesforce net profit estimate is $10.8b . This is 49.83% higher than the net profit for the last 12 months(TTM). The highest net profit forecast is $11.5b 59.69% , the lowest is $10.3b 42.78% .
This results in the following potential growth metrics and future Net Margins:
| 2025 | $6.2b | 49.83% |
|---|---|---|
| 2026 | $10.8b | 74.61% |
| 2027 | $12.1b | 11.88% |
| 2028 | $13.8b | 13.77% |
| 2029 | $16.0b | 16.29% |
| 2030 | $18.2b | 13.56% |
| 2031 | $20.3b | 11.61% |
| 2032 | $22.7b | 11.98% |
| 2033 | $25.8b | 13.58% |
| 2025 | 16.35% | 37.82% |
|---|---|---|
| 2026 | 25.97% | 58.81% |
| 2027 | 26.66% | 2.66% |
| 2028 | 27.78% | 4.20% |
| 2029 | 29.21% | 5.15% |
| 2030 | 30.32% | 3.80% |
| 2031 | 30.93% | 2.01% |
| 2032 | 31.48% | 1.78% |
| 2033 | 32.45% | 3.08% |
56 Analysts have issued a Salesforce forecast for earnings per share. The average Salesforce EPS is $11.49 . This is 51.58% higher than earnings per share in the financial year 2025. The highest EPS forecast is $12.24 61.48% , the lowest is $10.95 44.46% .
This results in the following potential growth metrics and future valuations:
| 2025 | $6.36 | 51.43% |
|---|---|---|
| 2026 | $11.49 | 80.66% |
| 2027 | $12.85 | 11.84% |
| 2028 | $14.62 | 13.77% |
| 2029 | $17.00 | 16.28% |
| 2030 | $19.31 | 13.59% |
| 2031 | $21.55 | 11.60% |
| 2032 | $24.13 | 11.97% |
| 2033 | $27.41 | 13.59% |
| Current | 34.60 | 41.23% |
|---|---|---|
| 2026 | 22.83 | 34.01% |
| 2027 | 20.40 | 10.64% |
| 2028 | 17.94 | 12.06% |
| 2029 | 15.42 | 14.05% |
| 2030 | 13.58 | 11.93% |
| 2031 | 12.17 | 10.38% |
| 2032 | 10.87 | 10.68% |
| 2033 | 9.57 | 11.96% |
Based on analysts' sales estimates for 2026, the Salesforce stock is valued at an EV/Sales of 5.83 and an P/S ratio of 5.90 .
This results in the following potential growth metrics and future valuations:
| Current | 6.02 | 34.57% |
|---|---|---|
| 2026 | 5.83 | 3.18% |
| 2027 | 5.35 | 8.26% |
| 2028 | 4.90 | 8.41% |
| 2029 | 4.43 | 9.57% |
| 2030 | 4.05 | 8.59% |
| 2031 | 3.70 | 8.61% |
| 2032 | 3.36 | 9.10% |
| 2033 | 3.05 | 9.24% |
| Current | 6.09 | 34.58% |
|---|---|---|
| 2026 | 5.90 | 3.23% |
| 2027 | 5.41 | 8.26% |
| 2028 | 4.96 | 8.41% |
| 2029 | 4.48 | 9.57% |
| 2030 | 4.10 | 8.59% |
| 2031 | 3.74 | 8.61% |
| 2032 | 3.40 | 9.10% |
| 2033 | 3.09 | 9.24% |
| Analyst | Rating | Action | Date |
|---|---|---|---|
| Morgan Stanley |
Overweight
➜
Overweight
|
Unchanged | Dec 09 2025 |
| Citigroup |
Neutral
➜
Neutral
|
Unchanged | Dec 08 2025 |
| DA Davidson |
Neutral
➜
Neutral
|
Unchanged | Dec 05 2025 |
| Barclays |
Overweight
➜
Overweight
|
Unchanged | Dec 04 2025 |
| Baird |
Outperform
➜
Outperform
|
Unchanged | Dec 04 2025 |
| BMO Capital |
Outperform
➜
Outperform
|
Unchanged | Dec 04 2025 |
| Canaccord Genuity |
Buy
➜
Buy
|
Unchanged | Dec 04 2025 |
| Analyst Rating | Date |
|---|---|
|
Unchanged
Morgan Stanley:
Overweight
➜
Overweight
|
Dec 09 2025 |
|
Unchanged
Citigroup:
Neutral
➜
Neutral
|
Dec 08 2025 |
|
Unchanged
DA Davidson:
Neutral
➜
Neutral
|
Dec 05 2025 |
|
Unchanged
Barclays:
Overweight
➜
Overweight
|
Dec 04 2025 |
|
Unchanged
Baird:
Outperform
➜
Outperform
|
Dec 04 2025 |
|
Unchanged
BMO Capital:
Outperform
➜
Outperform
|
Dec 04 2025 |
|
Unchanged
Canaccord Genuity:
Buy
➜
Buy
|
Dec 04 2025 |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.


